NASDAQ: EPIX - ESSA Pharma Inc.

Yield per half year: -64.5%
Dividend yield: 0.00%
Sector: Healthcare

Share chart ESSA Pharma Inc.

Extended chart Simple chart
Financial Markets by TradingView

About ESSA Pharma Inc.

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. The company develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. It has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2015-07-09
ISIN CA29668H7085
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.essapharma.com
Цена ао 8.85
Change price per day: +8.7% (1.61)
Change price per week: +9.38% (1.6)
Change price per month: -2.23% (1.79)
Change price per 3 month: -72.83% (6.44)
Change price per half year: -64.5% (4.93)
Change price per year: -73.48% (6.6)
Change price per 3 year: -86.49% (12.95)
Change price per 5 year: -67.29% (5.35)
Change price per 10 year: 0% (1.75)
Change price per year to date: -2.78% (1.8)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 0.8607 9
P/E 0 0
EV/EBITDA -3.47 0
Total: 3.63

Efficiency

Title Value Grade
ROA, % -17.83 0
ROE, % -18.25 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.003 10
Total: 9.6

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 118.64 10
Yield EPS, % -51.38 0
Total: 5.6
More

Institutions Volume Share, %
BVF Inc. 8748629 19.78
Bellevue Group AG 7898583 17.85
Soleus Capital Management, L.P. 4327622 9.78
Morgan Stanley 4186578 9.46
PFM Health Sciences, LP 3262500 7.37
RTW Investments LP 2298662 5.2
Adage Capital Partners GP L.L.C. 1135931 2.57
Janus Henderson Group PLC 1089482 2.46
Rock Springs Capital Management, LP 677005 1.53
Rhenman & Partners Asset Management AB 356500 0.81

ETF Share, % Profitability for 1 year, % Dividends, %
Avantis U.S Small Cap Equity ETF 0.02262 27.77 1.68271



Head Job title Payment Year of birth
Dr. David Ross Parkinson M.D. President, CEO & Director 814.15k 1950 (75 years)
Mr. David S. Wood C.M.A., CPA, CMA, CPA, M.B.A., MBA Chief Financial Officer 590.39k 1957 (68 years)
Mr. Peter A. Virsik M.B.A., M.S. Executive VP & COO 645.95k 1971 (54 years)
Dr. Alessandra Cesano M.D., Ph.D. Chief Medical Officer & Executive VP 623.93k 1961 (64 years)
Chandtip Chandhasin Executive N/A
Erica Osbourne Executive N/A
Erin Rudsinski Executive N/A
Loleta Harris Executive N/A
Neil Thapar Executive N/A
Nkengyal Barber Executive N/A

Address: Canada, Vancouver. BC VZ K, 999 West Broadway - open in Google maps, open in Yandex maps
Website: https://www.essapharma.com